Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01592097
Recruitment Status : Completed
First Posted : May 7, 2012
Last Update Posted : May 3, 2018
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Lilyana Amezcua, University of Southern California

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2018
  Actual Study Completion Date : April 2018